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Do You Really Get What You Paid For?
Abstract
[T]he purpose of my research is to analyze the efficiency of the US health care system through a panel
data analysis of the 19 OECD countries listed above (including the US) spanning the years 1990 to 2006
using an Ordinary Least Squares (OLS) regression of a Cobb-Douglas production function. I intend to
improve upon previous estimates by utilizing the most recent data available, including better and more
specific proxies for certain variables, and only including countries whose performance is truly comparable
to that of the US by removing the low performing outliers that fall into a separate efficiency and income
bracket of their own.
The format of my paper is as follows: Section II provides a review of previous literature on the topic of
health care system efficiency, Section III summarizes the theoretical model I employ in my research,
Section IV outlines my empirical model and data, Section V reports my results, Section VI offers a
summation of my findings and Section VII suggests potential venues for further research.
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Do You Really Get What You Paid For?

Analyzing the Productive Efficiency of U.S. Health Care
AMANDA CLAYTON

I. Introduction
Recent health care policy reforms proposed by
President Obama have prompted an increased
interest in the efficiency of the US health care
system. Looking at total health expenditure and life
expectancy alone, the President has good reason to
be hasty in his desire for change. Comparing the US
to 18 other Organization of Economic Cooperation
and Development (OECD) member countries at
similar levels of development; namely: Austria,
Australia, Belgium, Canada, Denmark, Finland,
France, Germany, Greece, Iceland, Ireland, Italy,
Japan, the Netherlands, Portugal, Spain,
Switzerland, and the UK; one finds that the US has
much to improve upon in these areas. In 2006, the
US spent approximately 15.1% of its GDP on health
care, more than any other OECD country and
considerably larger than the 9.0% average of its peer
nations (OECD Health Data, 2009). This is quite
negatively juxtaposed with the fact that the US also
has the lowest female and male life expectancies at
birth of the same 18 OECD nations. The US female
life expectancy at birth is 80.7 years (tied with
Denmark), falling 2.1 years below the average of 82.8
years; the US male life expectancy at birth is 75.4
years, again, falling two years below the average of
77.4 years (OECD Health Data, 2009). This raw and
partial evidence suggests that the US health care
system may be performing inefficiently compared to
its peer nations.
Of course, there are many factors outside of health
care that effect life expectancy at birth such as
lifestyle choices regarding the consumption of
tobacco, alcohol, and non-nutritious foods, pollution
levels, external causes of death from accidents or
crime, and socio-economic factors such as GDP per
capita or average education levels (Joumard, Isabelle
et al., 2008). It is therefore not accurate to assume
that inefficient health care is the sole cause of low
life expectancies in the US without taking these
other factors into account. For this reason, the
purpose of my research is to analyze the efficiency of
the US health care system through a panel data
analysis of the 19 OECD countries listed above
(including the US) spanning the years 1990 to 2006
using an Ordinary Least Squares (OLS) regression of

a Cobb-Douglas production function. I intend to
improve upon previous estimates by utilizing the
most recent data available, including better and
more specific proxies for certain variables, and only
including countries whose performance is truly
comparable to that of the US by removing the low
performing outliers that fall into a separate
efficiency and income bracket of their own.
The format of my paper is as follows: Section II
provides a review of previous literature on the topic
of health care system efficiency, Section III
summarizes the theoretical model I employ in my
research, Section IV outlines my empirical model
and data, Section V reports my results, Section VI
offers a summation of my findings and Section VII
suggests potential venues for further research.
II. Literature Review
Several studies have sought to compare the
efficiency of health care systems of OECD countries
in recent years. Most empirical studies have focused
on assessing and comparing the efficiency of all
OECD countries without specific attention to the
relative performance of a particular nation. For this
reason, most studies include all OECD countries for
which the desired variables are available over the
desired period. Looking at the efficiency of all OECD
nations however, ignores certain biases that may
skew efficiency results. A recent OECD working
paper used several measures to analyze the efficiency
of OECD nations and found that the OECD countries
could be separated into three different groups based
on health outcome results. The lowest group
included the Czech Republic, Hungary, Mexico,
Poland, the Slovak Republic, and Turkey (Joumard
et al., 2008). This group had average life
expectancies at birth that were four to five years
lower than the average of the second performance
group and had over seven more infant mortalities
per 1,000 live births on average than the second
performance group (Joumard et al., 2008). The
differences between the second and first
performance groups were much less extreme with
differences in average life expectancies of about two
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years and differences in average infant mortality
rates of less than one death per 1,000 live births
(Joumard et al., 2008). My sample will include the
first two performance groups but will exclude the
third, along with Korea, in order to create a more
homogenous group of nations in terms of
development. This decision will be described further
in Section IV.
A major matter of debate in health system efficiency
analysis is what variable is best to use as the output
of a health care production function. Most studies
contend that health outcomes are better to use than
measures of health care activity such as number of
physician visits, CT scans, etc. (Garber and Skinner,
2008; Joumard et al., 2008; Or, Wang, and
Jamison, 2004). Or, Wang and Jamison suggest that
focusing efficiency analysis on measures of health
care activity doesn‘t look at the goal of health care,
which is to improve patient health (2004). It is also a
general consensus that health care activity analysis
leads to negative incentives of overuse in health care
as countries try to increase the quantity of health
care provided rather than the quality provided. Even
though it is largely agreed upon that health
outcomes are a more accurate and appropriate
measure of health care outputs, the vast array of
potential measures of health outcomes leads to
questions of which measure is best to use.
Measures of mortality rates and average life
expectancies are the most widely available measures
of overall health outcomes to date. The main
problem with these measures however is the lack of
specificity as to the inputs that go into them. As
mentioned in the introduction, a person‘s life
expectancy is determined by many factors outside of
health care such as lifestyle choices, pollution, and
external causes such as accidents and murder. It is
difficult to separate these non-health-care-related
components from the effects of health care. For this
reason, several studies have looked at specific case
studies of survival rates after or treatment of specific
diseases (Preston and Ho, 2009). While these
measures give good data on the effectiveness of
specific health care treatments across countries, they
cannot be expected to provide information on the
overall efficiency of a health care system (Joumard
et al., 2008). Therefore, despite the overinclusiveness of mortality measures, most studies
find that they are the best proxies of health outcomes
currently available (Joumard et al., 2008; Or, Wang,
and Jamison, 2004). By controlling for as many of
the non-health-care-related inputs to life expectancy
as possible, one can ascertain a fairly accurate
picture of the specific effects of the health care
industry on patient life expectancy.

The most common control variables for non-healthcare-related inputs used in recent studies have been
tobacco and/or alcohol use, diet, pollution,
education levels, and GDP (Joumard et al., 2008;
Or, Wang, and Jamison, 2004). A problem area with
recent studies is their choice of proxies used for diet
and exercise. Or, Wang, and Jamison completely
neglected this variable in their study (2004) and
Joumard et al. used the number of fruits and
vegetables consumed as a proxy for diet and exercise
(2008). This proxy, however, does not actually
account for exercise and they had problems with the
significance and robustness of the variable due to
time lag issues. A person‘s diet now is likely to have
stronger effects on her future health than it does on
her current health. An overweight and diabetic
individual who has consumed unhealthy foods and
exercised little throughout her life but has recently
began to improve her diet through the increased
consumption of fruits and vegetables is unlikely to
see a change in her health status for some time.
Simply measuring the consumption of fruit and
vegetables does not account for these lagged effects.
Obesity is a much better proxy for diet and exercise
since it measures the current negative health effects
of an extended period of poor diet and exercise.
Obesity has not been used in previous studies due to
data availability, primarily because of differences in
measurement techniques. Some countries use survey
data to measure individuals‘ body mass index (BMI)
while others use actual measures of individuals‘
height and weight creating differences in obesity
rates across countries (OECD 2009 Health Data). It
is hypothesized that countries using actual measures
of height and weight have higher obesity rates than
countries in which survey data is used since people
are likely to underestimate, intentionally or not,
their weight when asked. Of the countries included
in my study, Australia, Japan, the UK, and the US
use actual measures of height and weight rather than
survey data (OECD 2009 Health Data). While
Australia, the UK, and the US have higher obesity
rates than the other peer nations, Japan has the
lowest rates of the OECD nations, suggesting that
the bias may be less extreme than is hypothesized.
Also, since I am estimating the efficiency of health
care in the US specifically, and since the US has the
highest obesity rates of all of the countries in my
analysis, the efficiency estimates of the US would
most likely be biased upwards if the obesity data of
other nations is truly inaccurate and biased
downwards. This is because the US will experience a
larger negative impact on health outcomes due to
obesity, thus reducing the negative impact to be
absorbed by health care inefficiency. Because most
studies have found that the US lies on the low side of
efficiency rankings compared to other OECD
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countries (Garber and Skinner, 2008; Joumard et
al., 2008; Or, Wang, and Jamison, 2004), including
obesity as a control variable would only help the US
in its efficiency estimates. I therefore use obesity
rates in my analysis despite these differences in
measurements.
Studies vary in their choices of medical inputs as
well. Most use either the number of physicians,
hospital beds, or CT scanners as physical measures
of inputs or use total, public, or private health
expenditure as monetary measures of inputs, but few
have used both physical and monetary measures
simultaneously. Physical and monetary input
measures are generally seen as substitute proxies for
health care inputs. For example, Wang, Jamison,
and Or used the number of practicing physicians per
1,000 people because they did not feel that adequate
measures of health expenditure were available
III. Theory
I use a Cobb-Douglas production function in my
research to analyze the efficiency of the US health
care system compared to its peer nations. A
production function allows me to, in theory, asses
the efficiency with which a nation uses its health care
inputs to produce an optimal level of health output.
A Cobb-Douglas production function is of the
generic form

where Y represents output, L represents labor
inputs, K represents capital inputs, and A is a
technological parameter. In the context of health
care efficiency, the theoretical model that I regress is

(2004). Joumard et al. ran separate regressions
using the number of practicing physicians in one set
of regressions and total health expenditure in the
other set (2008). Joumard et al. claim that increases
in total health expenditure leads to more practicing
physicians but I feel that this assumption only holds
under the assumption that the wages paid to
physicians are equal across countries, which is not
the case. An increase in total expenditure of 155,000
US$ would buy Germany two more physicians while
it would not even pay for one extra physician in the
United States according to the average physician
incomes reported by Garber and Skinner from the
OECD 2007 Health Data (2008). I therefore believe
that it would be acceptable to use the number of
practicing physicians as a proxy for labor inputs and
total health expenditure as a proxy for other health
care inputs as well as the emphasis placed on
healthcare by each country.
Health Outcomes = α(L)β1(K)β2(socioeconomic)β3
(lifestyle)β4
where
include income
levels and equality, institutional parameters, and
education and
include tobacco
and alcohol use, diet, and exercise. Representing
as HO,
as
SC, and
as LC, and transposing
the equation into log linear form for the sake of
running an OLS regression, I have

where εit is the error term of country i in time t.

IV. Empirical Model
My data come from the OECD 2009 Health Data set.
I use cross-sectional data analyzed over time and
include dummy variables for each country in order to
absorb the country effects which are otherwise
unaccounted for in my model. The 19 OECD
countries I analyze are Australia, Austria, Belgium,
Canada, Denmark, Finland, France, Germany,
Greece, Iceland, Ireland, Italy, Japan, the
Netherlands, Portugal, Spain, Switzerland, the United
Kingdom, and the United States. I chose to eliminate
the six
countries mentioned in Section II as being in the
lowest performance group among the OECD nations,
along with Korea, from my analysis due to their GDP

per capita income levels which were all below 20,000
US$ in 2007(OECD 2009 Health Data). The average
GDP per capita of the 19 OECD countries I have
chosen to analyze was a little under 44,000 US$ in
2007 (OECD 2009Health Data). It does not seem
accurate to include nations with less than half of the
income level of the average of the other countries in
the analysis. Furthermore, the GDP per capita of the
US in 2007 was a little over $45,000, implying that
removing these lower income nations creates a less
biased cross country comparison of the efficiency of
the United States compared to its peer nations.
Because of the income levels of these seven nations
and further because of the findings in the OECD
working paper cited in Section II, the Czech Republic,
Hungary, Mexico, Poland, the Slovak Republic,
Turkey, and Korea will excluded from my
comparative analysis.

The Park Place Economist, Volume XVIII 11

In the case of holes in data availability, I assume that
the change from one available point to the next is
linear which is generally evinced through the
adjacent, complete strings of data. In a few instances,
I continue to increase or decrease variables beyond
the given endpoints following the same linear pattern
of the preceding data points. To extend the endpoints
of strings of data that are otherwise fully complete, I
run regressions of the variable against time to find
the average increase or decrease in the variable per
year, and fill in the missing data accordingly.
As a proxy for health outcomes, I run separate
regressions using the average life expectancies of men
and women at birth and at age 60 since a large
portion of health expenditure is spent on senior
citizens (Joumard et al., 2008). The OECD 2009
Health Data includes a unique measure of potential
life years lost which weights deaths of younger
individuals higher than those of older individuals.
Included in these measures is potential life years lost
due to external causes which includes deaths from
accidents and murder. As suggested by Joumard et
al., I obtain a measure for potential life years lost due
to health related issues by subtracting potential life
years lost due to external causes from potential life
years lost from all causes. This removes a small
amount of bias in the health outcome measure used.
To further reduce the bias of non-health-care related
variables, I include several control variables that
account for outside effects on health outcomes.
lnLEit = α + β1 ln Physit + β2 ln HealthExpit + β3 ln
Tobit + β4 ln Alcit + β5 ln Obeseit + β6 ln GDPit +
β7CountryDummy + εit
For the variable Phys I run separate regressions using
both the total number of practicing physicians and
the number of practicing general practitioners.
Likewise, for the variable HealthExp I run separate
regressions using both total health expenditure per

As socio-economic controls, I include GDP per capita
which has been found to be significant in previous
studies. Unfortunately, due to data availability, I am
unable to include a proxy for educational attainment
which has also been found to be significant in
previous studies. I do not include parameters for
institutional differences because it is too difficult to
disentangle the combinations of institutional
frameworks enacted by individual countries
(Joumard et al., 2008). As lifestyle controls, I include
the percentage of the population over age 15 who
smoke daily, alcohol consumption in liters per capita,
and the percentage of the population that is obese. I
use the number of practicing physicians as well as the
total expenditure on health as measures of health
care inputs for the reasons stated in the literature
review. I also run a slightly more limited regression
removing Japan due to data unavailability, using the
number of practicing general practitioners in the
place of the number of practicing physicians. I do this
because of the growing international concerns that
there will be shortages of general practitioners in the
near future. I also feel that the ratio of general
practitioners to specialists contributes significantly to
improving the health outcomes as well as the cost
effectiveness of a health care system.
My empirical model is shown below along with Table
1 which provides the descriptive statistics of my
dependent and independent variables.
capita and total health expenditure as a percentage of
GDP. CountryDummy represents separate dummy
variables for each country with the US as the
excluded case. The coefficients of these dummy
variables will give me an indication of the
performance of the other peer nations, relative to that
of the US, holding the effects of the other variables
constant. The brunt of my analysis will be formed
from the values of these coefficients.
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Table 1: Descriptive Statistics
Variable

Description

Dependent Variables
LEFbirth
Life expectancy of females at birth
(Years)
LEMbirth
Life expectancy of males at birth
(Years)
LEF60
Life expectancy of females at age 60
(Years)
LEM60
Life expectancy of males at age 60
(Years)
PotLifeLostMed
Potential years of life lost minus
those due to external causes
(years per 100,000 people 0-69)
Independent Variables
HealthExpGDP
Total expenditure on health
(+ LE, - PLL)
(% of GDP)
HealthExpCap
Total expenditure on health per capita
(+ LE, - PLL)
(US$ exchange rate)
GDP
GDP per capita
(+ LE, - PLL)
(US$ exchange rate)
Alcohol
Alcohol consumption of those 15+
(- LE, + PLL)
(liters per capita)
Tobacco
Tobacco consumption of those 15+
(- LE, + PLL)
(% of population who smoke daily)
Obese
Body weight and composition
(- LE, + PLL)
(% of population who are obese)
GenPract
Practicing General Practitioners
(+ LE, - PLL)
(Density per 1,000 people)
TotalPhys
Practicing Physicians
(+ LE, - PLL)
(Density per 1,000 people)

N

Min

Max

Mean Std. Deviation

367

77

86

80.93

1.699

367

70

80

74.93

1.980

363

20

28

23.75

1.376

363

17

23

19.58

1.332

353

1679

5220

3111.15

655.622

362

5

15

8.42

1.734

376

341

7290 2368.10

1216.764

380 5398 64135 26225.46

10166.138

354

5

16

10.61

2.369

352

15

45

27.44

5.897

291

2

34

12.12

6.190

303

0

2

1.02

.499

345

2

12

2.93

.855

V. Results
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Table 2: Comparison of Means:
US vs. Peer Nations
Peer Nations

As is shown by Table 2, the US spends a larger
portion on health care as a percentage of GDP than
the mean of its peer nations by over one and a half
times throughout the period of regression. High
health expenditure in the US is accompanied by a
lower mean number of practicing general
practitioners and total physicians, lower mean life
expectancies, as well as more mean potential life
years lost than the means of its peer nations. The
areas in which the US has a more favorable mean
over the period than its peer nations is in the use of
alcohol and tobacco while the mean obesity rate of
the US relative to its peer nations is over twice as
large. In combination, these raw data
suggest that the US performs less efficiently than its
peer nations over the period of regression.
The strongest models in my regression include total
health expenditure as a percentage of GDP rather
than total health expenditure in per capita terms.
This is because including lnHealthExpCap made
lnGDP insignificant and because lnHealthExpCap
and lnGDP have a Pearson Correlation of .951 that is
significant at the .01 level while lnHealthExpGDP and
lnGDP have a Pearson Correlation of only .521
though it is still significant at the .01 level. I also
exclude Obese because it is found to be insignificant
and to have the wrong sign, implying that an increase
in obesity leads to an increase in life expectancy and a
decrease in potential life years lost. This is likely due
to the poor quality of the data and removing this
variable seems to be the appropriate decision to
improve the model. Table 3 displays the results of the
five separate dependent variables regressed against
lnTotalPhys.
Almost all coefficients are significant at the .001 level
and all have the expected signs. The adjusted R2
values are all between 86.5% and 91.9% suggesting a
good fit of the data. While all of the coefficients are
significant, some are larger than others. It is
important to note that the mean value of potential life
years lost due to medical or health related causes in
the nations included in the regression is 3,111.15 years
per 100,000 people. Thus, coefficients of the
independent variables regressed against
lnPotLifeLostMed are expected to be larger than
those regressed against life expectancy. The results

HealthExpGDP
8.136
13.215
GDP
25927.66
31585.85
Alcohol
10.725
8.558
Tobacco
27.867
20.275
Obese
11.147
28.838
GenPract
1.0286
.9253
TotalPhys
2.9544
2.2980
LEFbirth
81.010
79.395
LEMbirth
75.011
73.384
LEF60
23.780
23.205
LEM60
19.585
19.500
PotLifeLostMed
3061.10
4042.56
consistently suggest that decreasing smoking has the
largest positive effect on health outcomes while
increasing the number of total practicing physicians
has the smallest positive impact on health outcomes.
The coefficients of the country dummy variables are
of extreme importance in the model. These
coefficients show the difference in health outcomes
between a given country relative to that of the US
holding all other effects in the model constant. All of
the country coefficients are significant at the .001
level and all have signs suggesting better health
outputs than that of the US. The largest positive
difference is almost always held by Japan with the
exception of male life expectancy both at birth and at
age 60 in which Japan has the second and third
highest difference from that of the US respectively.
The country with the smallest difference from the US
varies from measure to measure with the smallest
overall difference being a higher female life
expectancy at birth in Denmark of .031 years or about
4 months holding all else constant. The main issue in
interpretation of the country coefficients is that it is
impossible to tell what each coefficient is picking up.
The difference cannot be entirely attributed to
inefficiency, particularly since measures for obesity,
pollution levels and education rates which are likely
to have significant effects on health outputs are not
included.

Table 3: Regression Results Including lnTotalPhys as an Independent Variable
(Constant)
LnHealthExpGDP
LnGDP

US

lnPotLifeLostMed

lnLEFbirth

lnLEF60

lnLEMbirth

lnLEM60

8.562***
-.288***
-.163***

4.264***
.026***
.019***

2.815***
.051**
.057***

4.190***
.033***
.028***

2.485***
.088***
.085***
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LnTobacco
LnAlcohol
LnTotalPhys
AUS
AUSL
BELG
CAND
DEN
FIN
FRAN
GERM
GRE
ICE
IRE
ITALY
Table 3 Continued
JAPAN
NETH
PORT
SPAIN
SWITZ
UK
R2

.577***
.256***
-.132***
-.709***
-.656***
-.648***
-.583***
-.649***
-.661***
-.638***
-.478***
-.970***
-.711***
-.838***
-.630***

-.040***
-.021***
.012***
.056***
.047***
.049***
.049***
.031***
.046***
.070***
.037***
.069***
.036***
.051***
.063***

-.100***
-.056***
.031***
.117***
.085***
.101***
.104***
.039***
.079***
.170***
.062***
.132***
.049***
.078***
.127***

-.071***
-.037***
.020***
.075***
.061***
.060***
.065***
.065***
.039***
.068***
.046***
.114***
.061***
.085***
.074***

-.172***
-.073***
.055***
.144***
.096***
.096***
.124***
.084***
.059***
.155***
.057***
.254***
.099***
.126***
.131***

-1.066***
-.774***
-.339***
-.907***
-.665***
-.685***

.098***
.055***
.042***
.092***
.057***
.048***

.223***
.107***
.085***
.206***
.122***
.081***

.109***
.085***
.044***
.107***
.070***
.083***

.224***
.124***
.107***
.243***
.120***
.137***

.906

.919

.913

.879

.865

*** significant at the .001 level ** significant at the .01 level
Upon replacing the independent variable lnTotalPhys
with lnGenPract some interesting results are found.
Table 4 displays these results. Due to data availability

of the number of practicing general practitioners,
Japan has been removed from this series of
regressions.

Table 4: Regression Results Including lnGenPract as an Independent Variable
(Constant)
LnHealthExpGDP
LnGDP
LnTobacco
LnAlcohol
LnGenPract
AUS
AUSL
BELG
CAND
DEN
FIN
FRAN
GERM
GRE

lnPotLifeLostMed

lnLEFbirth

lnLEF60

lnLEMbirth

lnLEM60

8.606***
-.379***
-.166***
.569***
.314***
-.172
-.719***
-.688***
-.636***
-.586***
-.779***
-.764***
-.646***
-.482***
-1.337***

4.252***
.031***
.020***
-.037***
-.026***
.025**
.052***
.045***
.038***
.047***
.043***
.056***
.064***
.031***
.108***

2.777***
.064**
.061***
-.091***
-.073***
.058*
.108***
.084***
.079**
.099***
.068***
.102***
.159***
.051**
.220***

4.163***
.053***
.029***
-.067***
-.047***
.041***
.074***
.062***
.048***
.065***
.091***
.062***
.063***
.041***
.180***

2.431***
.134***
.086***
-.163***
-.096***
.121***
.134***
.091***
.052
.122***
.152***
.118***
.130***
.037
.440***
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ICE
IRE
ITALY
NETH
PORT
SPAIN
SWITZ
UK
R2

-.837***
-1.062***
-.737***
-.986***
-.363***
-.989***
-.893***
-.799***

.048***
.075***
.071***
.078***
.038***
.094***
.084***
.059***

.078***
.138***
.148***
.162***
.082***
.210***
.185***
.108***

.086***
.133***
.095***
.131***
.043***
.121***
.118***
.110***

.168***
.256***
.183***
.249***
.094**
.266***
.255***
.207***

.896

.893

.884

.882

.863

*** significant at the .001 level ** significant at the .01 level * significant at the .02 level
The coefficient to the number of practicing general
practitioners is not found to be statistically significant
when regressed against potential life years lost due to
medical or health related causes and the adjusted R2
value decreases for most of the new regressions.
However, the values of the adjusted R2 terms are all
still between 86.3% and 89.3% suggesting good
overall explanatory power. Furthermore, the
coefficients for lnGenPract are all still significant at
the .02 level or lower when regressed against the
measures of life expectancy. Table 5 shows the
important difference in the values of the coefficients
for lnTotalPhys versus lnGenPract. While the

significance level of the coefficients for lnGenPract is
generally smaller, the size of the coefficients
regressed against various measures of life expectancy
are approximately twice that of the coefficients for
lnTotalPhys. This implies that increasing the number
of practicing general practitioners could have a
stronger positive impact on life expectancy than
increasing the total number of practicing physicians
without regard to their field of practice. There were
slight increases and decreases in the coefficients of
the other variables, but none of the differences were
as large as the change in effect of the number of
physicians.

Table 5: Coefficients for lnTotalPhys and lnGenPract
lnPotLifeLostMed
lnLEFbirth
lnLEF60
TotPhys

GenPract

TotalPhys

GenPract

TotalPhys

GenPract

lnLEF60
TotalPhys

GenPract

-.132***
-.172
.012***
.025**
.031***
.058*
.020***
.041***
*** significant at the .001 level ** significant at the .01 level * significant at the .02 level

lnLEM60
TotalPhys

GenPract

.055***

.121***

The explanation of the country dummy coefficients
when lnGenPract is included is similar to the results
found in the previous regressions The country
coefficients regressed against measures of life
expectancy and potential life years lost are again
mostly significant at the .001 level and have signs
suggesting that each peer nation has better health
outcomes than that of the US holding all other effects
constant. The exception is in the life expectancy of

males at age 60 in which the coefficients for Belgium
and Germany are found to be insignificant meaning
that, holding the other effects of the model constant,
Belgium and Germany do not experience significantly
higher life expectancies for males at age 60 than that
of the US.

VI. Conclusion

life expectancy than the number of total practicing
physicians has, suggesting that increasing the
number of general practitioners relative to specialists
would have a positive effect on health outcomes.
Smoking is found to have the largest impact on health
outcomes suggesting that smoking may outweigh the
positive effects of health care. The policy implications
of these results are often considered unappealing in
the political world as they involve increasing
government regulation and programs in health care.

As a whole, the regressions explain a large portion of
the variation in health outcomes, as measured by life
expectancy and potential life years lost, among the
OECD nations studied. The findings suggest that,
holding other effects constant, the US experiences
worse health outcomes than its peer nations. The
number of practicing general practitioners is found to
have approximately two times the positive effect on
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